Alterity Therapeutics (ATHE) Operating Expenses (2015 - 2025)

Alterity Therapeutics' Operating Expenses history runs 11 years deep, the most recent figure standing at $4.3 million for Q4 2025.

• In Q4 2025, Operating Expenses rose 600.99% year-over-year to $4.3 million; the TTM figure through Dec 2025 stood at $3.5 million (down 24.95% YoY), while the FY2025 annual figure was $12.7 million, up 100.2% from the prior year.
• Operating Expenses was $4.3 million for Q4 2025 at Alterity Therapeutics, up from -$863909.4 in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $5.5 million in Q4 2023 to a low of -$863909.4 in Q4 2024.
• Historically, Operating Expenses has averaged $3.4 million across 5 years, with a median of $4.2 million in 2022.
• The sharpest annual moves came in 2024 and 2025: Operating Expenses plunged 115.77% in 2024, then jumped 600.99% in 2025.
• A 5-year view of Operating Expenses shows it stood at $4.1 million in 2021, then increased by 2.34% to $4.2 million in 2022, then jumped by 31.26% to $5.5 million in 2023, then sank by 115.77% to -$863909.4 in 2024, then surged by 600.99% to $4.3 million in 2025.
• The last three Operating Expenses figures came in at $4.3 million (Q4 2025), -$863909.4 (Q4 2024), and $5.5 million (Q4 2023), per Business Quant data.